PrimeRFP
PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0221F0186OBIZUR emergency ORDER — Takeda Pharmaceuticals America, Inc

Takeda Pharmaceuticals America, Inc holds $6.5M across 96 federal awards, concentrated at Department of Justice (DOJ). This PIID sits alongside 4 related awards in the incumbent pipeline.

W40m Rhco Pacific
Awarding office
Takeda Pharmaceuticals America, Inc
Recipient
—
Estimated value
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Takeda Pharmaceuticals America, Inc — $90

Contract facts

Federal
Contract numberW81K0221F0186
Also listed asW81K02-21-F-0186
AgencyW40m Rhco Pacific
Awarding officeW40m Rhco Pacific
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentTakeda Pharmaceuticals America, Inc
UEIDDEVYUAXJ624
PSC6505

OBIZUR EMERGENCY ORDER is a federal award for W40m Rhco Pacific held by Takeda Pharmaceuticals America, Inc. Estimated value —.

Incumbent footprint

Public record

Takeda Pharmaceuticals America, Inc — $6.5M obligated across 96 awards (firm-wide, all agencies) · lead buyer Department of Justice (DOJ).

% of firm-wide obligated ($6.5M) · all agencies
Department of Justice (DOJ)$4.0M · 62%Department of Veterans Affairs (VA)$2.5M · 38%Department of Defense (DOD)$20K · 0%
Open full company profile →

Related awards

Same incumbent
15B50926F00000076
FY26 PHARMACEUTICALS TAKEDA APRIL-SEPTEMBER
$549K
Sep 30, 2026
15B50926F00000018
FY26 TAKEDA OCT-NOV
$320K
Sep 30, 2026
36C26026P0420
GAMMAGARD LIQUID ERC - GLOBULIN,IMMUNE (IV) 10% INJ
$108K
Sep 30, 2026
36C26026F0130
ADZYNMA 1500IU INJ,LYPHL.
$179K
Jan 3, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W81K0221F0186?

W81K0221F0186 (OBIZUR emergency ORDER) is a W40m Rhco Pacific award with an estimated value of —, currently held by Takeda Pharmaceuticals America, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81K02-21-F-0186?

W81K02-21-F-0186 is the dashed form of PIID W81K0221F0186 (OBIZUR emergency ORDER), held by Takeda Pharmaceuticals America, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81K0221F0186?

W40m Rhco Pacific awarded W81K0221F0186 to Takeda Pharmaceuticals America, Inc.

Who is the incumbent on W81K0221F0186?

Takeda Pharmaceuticals America, Inc is the incumbent with $6.5M across 96 related awards in SCOUT’s public footprint.

When does Takeda Pharmaceuticals America, Inc’s W81K0221F0186 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on W81K0221F0186 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W81K0221F0186